{"gene":"MRPL9","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":1992,"finding":"The yeast nuclear gene YmL9 (MRP-L9), ortholog of human MRPL9, was cloned and sequenced. The encoded protein is a basic 27.5 kDa protein with a putative N-terminal mitochondrial import signal peptide of 19 amino acids. The intact gene is essential for mitochondrial function. YmL9 shows significant sequence similarity to E. coli ribosomal protein L3 and related proteins from all three natural kingdoms, with the highest similarity to eubacterial and cyanelle homologues, locating the conserved structural domain in the C-terminal half.","method":"Gene cloning, sequencing, sequence homology analysis, yeast genetics (gene disruption showing essentiality)","journal":"European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 2 — direct gene disruption establishing essentiality, sequence characterization with ortholog identification; foundational paper","pmids":["1597181"],"is_preprint":false},{"year":2001,"finding":"MRPL9 (homolog of bacterial L9) was identified as a component of the mammalian mitochondrial ribosome large subunit (39S subunit). Proteolytic digestion of purified bovine 39S subunits followed by LC-MS/MS peptide sequencing confirmed MRPL9 as one of 28 bacterial homolog proteins in the 48-protein complement of the mammalian mt-LSU.","method":"Purification of 39S mitochondrial ribosomal subunit, proteolytic digestion, LC-MS/MS peptide sequencing, EST database searching","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical identification from purified ribosomal subunit with mass spectrometry","pmids":["11551941"],"is_preprint":false},{"year":2014,"finding":"MRPL9 was resolved as a structural component of the human mitochondrial large ribosomal subunit (mt-LSU) at 3.4 Å resolution by cryo-EM single-particle analysis. The structure revealed 48 proteins in the mt-LSU, including MRPL9, and showed extensive remodeling of the subunit compared to bacterial ribosomes, with adaptations including a modified exit tunnel for hydrophobic nascent peptides.","method":"Single-particle cryo-electron microscopy at 3.4 Å resolution","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 — near-atomic resolution cryo-EM structure placing MRPL9 within the mitoribosomal large subunit","pmids":["25278503"],"is_preprint":false},{"year":2017,"finding":"MRPL9 was resolved in cryo-EM structures of two late-stage assembly intermediates of the human mt-LSU at ~3 Å resolution, isolated from native cellular pools. These structures revealed the timing of protein incorporation during final steps of ribosomal maturation, showing that MRPL9 is present in the mature mt-LSU and providing insight into evolutionary adaptations required for mitoribosome biogenesis.","method":"Cryo-EM of native assembly intermediates isolated from human cells, ~3 Å resolution","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 — near-atomic cryo-EM of native ribosomal assembly intermediates","pmids":["28892042"],"is_preprint":false},{"year":2016,"finding":"MRPL9 was identified as part of the mitochondrial protein interaction network through affinity enrichment mass spectrometry, placing it within the large subunit of the mitochondrial ribosome and connecting it to diverse mitochondrial processes including respiratory chain function.","method":"Affinity enrichment mass spectrometry (condition-specific protein-protein interactions for mitochondrial proteins)","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2 — systematic AP-MS in mitochondrial context, single study","pmids":["27499296"],"is_preprint":false},{"year":2020,"finding":"MRPL9 was confirmed as a high-confidence component of the human mitochondrial proteome (MitoCoP) with defined abundance levels in human cells, contributing to approximately 7% of the cellular proteome occupied by mitochondrial proteins. Its protein half-life dynamics were measured, providing quantitative context for its role in mitoribosome assembly.","method":"Quantitative proteomics of mitochondrial preparations, SILAC-based turnover measurements","journal":"Cell metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — systematic quantitative proteomics with abundance and dynamics measurements","pmids":["34800366"],"is_preprint":false},{"year":2022,"finding":"MRPL9 was found to physically interact with GGCT (γ-glutamylcyclotransferase) in papillary thyroid cancer cells. This interaction was demonstrated by co-immunoprecipitation and immunofluorescence co-localization. Knockdown of either MRPL9 or GGCT inhibited MAPK/ERK signaling pathway activation, reduced cell proliferation and migration in vitro, and inhibited subcutaneous xenograft growth and lung metastasis formation in vivo. Conversely, lentiviral overexpression of MRPL9 promoted proliferation and migration.","method":"Co-immunoprecipitation, immunofluorescence co-localization, lentiviral overexpression, siRNA knockdown, xenograft mouse model, lung metastasis model, Western blot for p-ERK/ERK","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2–3 — reciprocal Co-IP and in vivo xenograft validation from single lab","pmids":["36233293"],"is_preprint":false},{"year":2023,"finding":"Knockdown of MRPL9 in hepatocellular carcinoma (HCC) cells inhibited cell proliferation (CCK8 assay), caused G1/S cell cycle arrest (flow cytometry), and reduced cell migration and invasion (Transwell assay). Overexpressed MRPL9 enhanced aggressiveness. Serum MRPL9 protein levels were significantly elevated in HCC patients compared to healthy individuals and benign liver disease patients, as measured by ELISA.","method":"siRNA knockdown, CCK8 proliferation assay, flow cytometry cell cycle analysis, Transwell migration/invasion assay, Western blot, ELISA on patient serum","journal":"Frontiers in surgery","confidence":"Medium","confidence_rationale":"Tier 2–3 — multiple cellular assays plus patient serum validation, single lab","pmids":["36684217"],"is_preprint":false},{"year":2023,"finding":"Knockdown of MRPL9 in lung cancer cells inhibited proliferation, sphere formation, and migration. MRPL9 was shown to be functionally associated with the c-MYC signaling pathway; interference with c-MYC expression reduced ZEB1 (an EMT regulator) levels, suggesting MRPL9 exerts its oncogenic effects through regulation of c-MYC which in turn controls ZEB1-mediated epithelial-mesenchymal transition.","method":"siRNA knockdown, proliferation assay, sphere-formation assay, migration assay, bioinformatics pathway analysis, siRNA interference of c-MYC with measurement of ZEB1 expression by Western blot","journal":"Pathology, research and practice","confidence":"Low","confidence_rationale":"Tier 3 — functional KD phenotype with pathway inference partly from bioinformatics; c-MYC/ZEB1 link relies on indirect evidence","pmids":["37343379"],"is_preprint":false},{"year":2025,"finding":"In vivo CRISPRa screening in mouse liver identified Mrpl9 as a driver gene of hepatocellular carcinoma. CRISPRa-mediated activation of Mrpl9 (together with oncogenic Myc) resulted in extensive liver tumorigenesis and decreased mouse survival. RNA sequencing of Mrpl9-activated tumors revealed that Mrpl9 upregulation specifically alters expression of genes functionally related to mitochondrial function, leading to promotion of cellular proliferation. This mechanism was distinct from co-identified drivers Vps72 (phospholipid metabolism) and Gba1 (endosomal-lysosomal activity).","method":"In vivo CRISPRa screening in mouse liver, RNA sequencing of tumor tissue, survival analysis of mice, validation by independent CRISPRa activation in separate mouse cohorts","journal":"Cellular and molecular gastroenterology and hepatology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo genetic gain-of-function screen with RNA-seq mechanistic follow-up and independent validation cohort","pmids":["39761726"],"is_preprint":false}],"current_model":"MRPL9 is a conserved, essential component of the mitochondrial ribosome large subunit (mt-LSU), structurally resolved by cryo-EM as a homolog of bacterial L3/L9, where it contributes to mitoribosomal integrity and mitochondrial translation; beyond its ribosomal role, MRPL9 overexpression drives cell proliferation, migration, and tumorigenesis—including as a bona fide HCC driver gene identified by in vivo CRISPRa screening—through mechanisms involving MAPK/ERK pathway activation (partly via physical interaction with GGCT), c-MYC/ZEB1-mediated EMT regulation in lung cancer, and broader alterations in mitochondrial function-related gene expression."},"narrative":{"teleology":[{"year":1992,"claim":"Cloning of the yeast ortholog YmL9 established that the MRPL9 gene family encodes a mitochondrial ribosomal protein homologous to bacterial L3, and gene disruption demonstrated its essentiality for mitochondrial function — answering whether this nuclear-encoded protein is required for organellar translation.","evidence":"Gene cloning, sequencing, and disruption in S. cerevisiae","pmids":["1597181"],"confidence":"High","gaps":["Mammalian MRPL9 not yet identified or characterized","Precise position within the ribosome unknown","Mechanism of mitochondrial import not defined"]},{"year":2001,"claim":"Direct biochemical identification of MRPL9 in purified bovine 39S subunits confirmed it as a bona fide mammalian mt-LSU component, resolving whether the bacterial homolog was retained in the heavily remodeled mammalian mitoribosome.","evidence":"Proteolytic digestion and LC-MS/MS of purified bovine 39S mitoribosomal subunits","pmids":["11551941"],"confidence":"High","gaps":["No structural information on MRPL9's position within the subunit","Functional contribution to translation not directly tested in mammalian cells"]},{"year":2014,"claim":"Cryo-EM structures of the human mt-LSU at 3.4 Å placed MRPL9 within the architectural context of the mature ribosome, revealing how mitoribosomal remodeling accommodates hydrophobic nascent chains — the first direct structural view of MRPL9 in situ.","evidence":"Single-particle cryo-EM at 3.4 Å resolution of human mt-LSU","pmids":["25278503"],"confidence":"High","gaps":["Timing of MRPL9 incorporation during ribosome assembly unknown","Functional contacts with rRNA or neighboring proteins not individually characterized"]},{"year":2017,"claim":"Resolution of native late-stage assembly intermediates showed that MRPL9 is present in pre-mature mt-LSU complexes, establishing its incorporation timing during mitoribosome biogenesis.","evidence":"Cryo-EM of native mt-LSU assembly intermediates at ~3 Å from human cells","pmids":["28892042"],"confidence":"High","gaps":["Specific assembly factors that recruit MRPL9 not identified","Consequence of MRPL9 depletion on assembly intermediate accumulation not tested"]},{"year":2022,"claim":"Discovery of a physical MRPL9–GGCT interaction linked MRPL9 to MAPK/ERK signaling and cancer cell proliferation/metastasis, raising the question of whether MRPL9 has extra-ribosomal oncogenic functions.","evidence":"Co-immunoprecipitation, immunofluorescence co-localization, xenograft and lung metastasis models in papillary thyroid cancer","pmids":["36233293"],"confidence":"Medium","gaps":["Whether the MRPL9–GGCT interaction occurs in the mitochondrial matrix or cytosol is unclear","Whether ERK activation is a direct consequence of the interaction or secondary to altered mitochondrial function is unresolved","Single-lab finding not yet independently replicated"]},{"year":2023,"claim":"Functional studies in HCC and lung cancer cells demonstrated that MRPL9 knockdown consistently suppresses proliferation, migration, and invasion, with evidence linking MRPL9 to c-MYC/ZEB1-mediated EMT in lung cancer — broadening the cancer types where MRPL9 overexpression is functionally relevant.","evidence":"siRNA knockdown with proliferation, migration, invasion, and cell cycle assays in HCC and lung cancer cell lines; patient serum ELISA; Western blot for c-MYC and ZEB1","pmids":["36684217","37343379"],"confidence":"Medium","gaps":["The c-MYC/ZEB1 link relies partly on bioinformatic inference and indirect knockdown experiments","Whether pro-tumorigenic effects depend on MRPL9's ribosomal function or an independent activity is unknown","Elevated serum MRPL9 in HCC patients not validated in independent cohorts"]},{"year":2025,"claim":"In vivo CRISPRa screening identified Mrpl9 as a bona fide hepatocellular carcinoma driver whose gain-of-function alters mitochondrial function gene programs and accelerates tumorigenesis, directly linking MRPL9's mitochondrial biology to its oncogenic capacity.","evidence":"In vivo CRISPRa screen in mouse liver with Myc co-activation, RNA-seq of tumors, independent validation cohorts","pmids":["39761726"],"confidence":"Medium","gaps":["Whether MRPL9-driven tumorigenesis requires intact mitoribosomal incorporation or occurs through a ribosome-independent mechanism is unresolved","Specific mitochondrial pathways altered (OXPHOS, ROS, metabolites) not dissected at protein level","Cooperation with Myc complicates attribution of tumor phenotype to MRPL9 alone"]},{"year":null,"claim":"It remains unknown whether the pro-tumorigenic effects of MRPL9 overexpression are mediated through enhanced mitochondrial translation, altered mitochondrial metabolism, extra-ribosomal protein interactions, or a combination of these mechanisms.","evidence":"","pmids":[],"confidence":"Low","gaps":["No separation-of-function mutants distinguishing ribosomal from extra-ribosomal roles","No structural basis for the MRPL9–GGCT interaction","Effects of MRPL9 loss on mitochondrial translation in mammalian cells not directly measured"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[1,2,3]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,1,2,3,4,5]},{"term_id":"GO:0005840","term_label":"ribosome","supporting_discovery_ids":[1,2,3]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[1,2,3]}],"complexes":["mitochondrial ribosome large subunit (39S)"],"partners":["GGCT"],"other_free_text":[]},"mechanistic_narrative":"MRPL9 is a conserved structural component of the mitochondrial ribosome large subunit (mt-LSU), essential for mitochondrial translation and oxidative phosphorylation. The protein was identified biochemically as one of 48 proteins of the mammalian 39S mt-LSU and resolved at near-atomic resolution by cryo-EM within both the mature mt-LSU and late-stage assembly intermediates, where it occupies a position homologous to bacterial ribosomal protein L9 [PMID:11551941, PMID:25278503, PMID:28892042]. Beyond its canonical ribosomal role, MRPL9 overexpression drives cell proliferation and tumorigenesis: in vivo CRISPRa screening identified Mrpl9 as a hepatocellular carcinoma driver gene whose activation alters mitochondrial function-related gene expression programs [PMID:39761726], while in papillary thyroid cancer cells MRPL9 physically interacts with GGCT to activate MAPK/ERK signaling and promote proliferation, migration, and metastasis [PMID:36233293]. Knockdown of MRPL9 in hepatocellular carcinoma and lung cancer cells consistently suppresses proliferation, migration, and invasion, with downstream effects on cell cycle progression and c-MYC/ZEB1-mediated epithelial–mesenchymal transition [PMID:36684217, PMID:37343379]."},"prefetch_data":{"uniprot":{"accession":"Q9BYD2","full_name":"Large ribosomal subunit protein bL9m","aliases":["39S ribosomal protein L9, mitochondrial","L9mt","MRP-L9"],"length_aa":267,"mass_kda":30.2,"function":"","subcellular_location":"Mitochondrion","url":"https://www.uniprot.org/uniprotkb/Q9BYD2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/MRPL9","classification":"Common Essential","n_dependent_lines":567,"n_total_lines":1208,"dependency_fraction":0.4693708609271523},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"RANBP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/MRPL9","total_profiled":1310},"omim":[{"mim_id":"620646","title":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 59; COXPD59","url":"https://www.omim.org/entry/620646"},{"mim_id":"611845","title":"MITOCHONDRIAL RIBOSOMAL PROTEIN L39; MRPL39","url":"https://www.omim.org/entry/611845"},{"mim_id":"611824","title":"MITOCHONDRIAL RIBOSOMAL PROTEIN L9; MRPL9","url":"https://www.omim.org/entry/611824"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Mitochondria","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MRPL9"},"hgnc":{"alias_symbol":["bL9m"],"prev_symbol":[]},"alphafold":{"accession":"Q9BYD2","domains":[{"cath_id":"3.40.5.10","chopping":"94-150","consensus_level":"high","plddt":94.8995,"start":94,"end":150},{"cath_id":"3.10.430.100","chopping":"160-240","consensus_level":"high","plddt":94.2431,"start":160,"end":240}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BYD2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BYD2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BYD2-F1-predicted_aligned_error_v6.png","plddt_mean":81.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MRPL9","jax_strain_url":"https://www.jax.org/strain/search?query=MRPL9"},"sequence":{"accession":"Q9BYD2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BYD2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BYD2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BYD2"}},"corpus_meta":[{"pmid":"32987154","id":"PMC_32987154","title":"Expression analysis of mammalian mitochondrial ribosomal protein genes.","date":"2020","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/32987154","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25296918","id":"PMC_25296918","title":"Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25296918","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1597181","id":"PMC_1597181","title":"YmL9, a nucleus-encoded mitochondrial ribosomal protein of yeast, is homologous to L3 ribosomal proteins from all natural kingdoms and photosynthetic organelles.","date":"1992","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1597181","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34703883","id":"PMC_34703883","title":"Transcriptional landscape associated with TNBC resistance to neoadjuvant chemotherapy revealed by single-cell RNA-seq.","date":"2021","source":"Molecular therapy oncolytics","url":"https://pubmed.ncbi.nlm.nih.gov/34703883","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36233293","id":"PMC_36233293","title":"Interaction of MRPL9 and GGCT Promotes Cell Proliferation and Migration by Activating the MAPK/ERK Pathway in Papillary Thyroid Cancer.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36233293","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34129020","id":"PMC_34129020","title":"Genome analysis of Candida subhashii reveals its hybrid nature and dual mitochondrial genome conformations.","date":"2021","source":"DNA research : an international journal for rapid publication of reports on genes and genomes","url":"https://pubmed.ncbi.nlm.nih.gov/34129020","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8701610","id":"PMC_8701610","title":"Sequence analysis of the 43 kb CRM1-YLM9-PET54-DIE2-SMI1-PHO81-YHB4-PFK1 region from the right arm of Saccharomyces cerevisiae chromosome VII.","date":"1996","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8701610","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36684217","id":"PMC_36684217","title":"Classification of the mitochondrial ribosomal protein-associated molecular subtypes and identified a serological diagnostic biomarker in hepatocellular carcinoma.","date":"2023","source":"Frontiers in surgery","url":"https://pubmed.ncbi.nlm.nih.gov/36684217","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37343379","id":"PMC_37343379","title":"Identification of a novel therapeutic target for lung cancer: Mitochondrial ribosome protein L9.","date":"2023","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/37343379","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39761726","id":"PMC_39761726","title":"In Vivo CRISPR Activation Screening Reveals Chromosome 1q Genes VPS72, GBA1, and MRPL9 Drive Hepatocellular Carcinoma.","date":"2025","source":"Cellular and molecular gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/39761726","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40406416","id":"PMC_40406416","title":"Genetic mechanisms of hemispheric functional connectivity in diabetic retinopathy: a joint neuroimaging and transcriptomic study.","date":"2025","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/40406416","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37895191","id":"PMC_37895191","title":"Identification of Missense Variants Affecting Carcass Traits for Hanwoo Precision Breeding.","date":"2023","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/37895191","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35674862","id":"PMC_35674862","title":"Long Non-coding RNA and mRNA Co-expression Network Reveals Novel Players in Pleomorphic Xanthoastrocytoma.","date":"2022","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/35674862","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41630109","id":"PMC_41630109","title":"MRPL13 deficiency triggers trophoblast mitochondrial unfolded protein response in early-onset preeclampsia.","date":"2026","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/41630109","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22681889","id":"PMC_22681889","title":"The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22681889","citation_count":973,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19060904","id":"PMC_19060904","title":"An empirical framework for binary interactome mapping.","date":"2008","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/19060904","citation_count":652,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29395067","id":"PMC_29395067","title":"High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29395067","citation_count":580,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21145461","id":"PMC_21145461","title":"Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21145461","citation_count":318,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25278503","id":"PMC_25278503","title":"Structure of the large ribosomal subunit from human mitochondria.","date":"2014","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/25278503","citation_count":262,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34800366","id":"PMC_34800366","title":"Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.","date":"2021","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34800366","citation_count":239,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27499296","id":"PMC_27499296","title":"Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27499296","citation_count":220,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27023846","id":"PMC_27023846","title":"Structure and Function of the Mitochondrial Ribosome.","date":"2016","source":"Annual review of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27023846","citation_count":217,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11551941","id":"PMC_11551941","title":"The large subunit of the mammalian mitochondrial ribosome. Analysis of the complement of ribosomal proteins present.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11551941","citation_count":216,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30833792","id":"PMC_30833792","title":"A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30833792","citation_count":159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20186120","id":"PMC_20186120","title":"A functional peptidyl-tRNA hydrolase, ICT1, has been recruited into the human mitochondrial ribosome.","date":"2010","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/20186120","citation_count":153,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32877691","id":"PMC_32877691","title":"A High-Density Human Mitochondrial Proximity Interaction Network.","date":"2020","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32877691","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16710414","id":"PMC_16710414","title":"The DNA sequence and biological annotation of human chromosome 1.","date":"2006","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16710414","citation_count":144,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31871319","id":"PMC_31871319","title":"Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31871319","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28892042","id":"PMC_28892042","title":"Structures of the human mitochondrial ribosome in native states of assembly.","date":"2017","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28892042","citation_count":136,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8667,"output_tokens":1573,"usd":0.024798},"stage2":{"model":"claude-opus-4-6","input_tokens":4829,"output_tokens":3192,"usd":0.155917},"total_usd":0.370848,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":19810,"output_tokens":4038,"usd":0.06},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6236,"output_tokens":2223,"usd":0.130133}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"Yeast YmL9 (MRP-L9/MRPL9 ortholog) is a nucleus-encoded mitochondrial ribosomal protein homologous to bacterial ribosomal protein L3; its gene is essential for mitochondrial function, and the protein contains a mitochondrial import signal peptide in its N-terminus.\",\n      \"method\": \"Gene cloning, sequence analysis, amino acid similarity comparison, genetic essentiality test in yeast\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational cloning/sequencing with genetic essentiality demonstrated, replicated across sequence databases\",\n      \"pmids\": [\"1597181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MRPL9 physically interacts with GGCT (γ-glutamylcyclotransferase) in papillary thyroid cancer cells, and this interaction activates the MAPK/ERK signaling pathway to promote cell proliferation and migration; knockdown of either MRPL9 or GGCT inhibited xenograft tumor growth and lung metastasis.\",\n      \"method\": \"Co-immunoprecipitation (Co-IP), immunofluorescence, lentiviral knockdown/overexpression, in vivo subcutaneous xenograft and lung metastasis models, Western blot for ERK pathway markers\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — reciprocal Co-IP with functional in vivo validation, but single lab and no structural or reconstitution data\",\n      \"pmids\": [\"36233293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MRPL9 knockdown in lung cancer cells inhibited proliferation, sphere-formation, and migration; MRPL9 was found to exert its effects through the c-MYC signaling pathway, which in turn regulates the EMT regulator ZEB1 (confirmed by c-MYC interference experiments).\",\n      \"method\": \"shRNA knockdown, proliferation/sphere/migration assays, bioinformatics pathway analysis, c-MYC interference with Western blot for ZEB1\",\n      \"journal\": \"Pathology, research and practice\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, mechanistic link to c-MYC/ZEB1 partially inferred from knockdown phenotype and bioinformatics\",\n      \"pmids\": [\"37343379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Overexpression of MRPL9 in hepatocellular carcinoma cells enhances cell proliferation, migration, and invasion, and promotes G1/S cell cycle progression; serum MRPL9 protein levels are elevated in HCC patients.\",\n      \"method\": \"Cell Counting Kit-8 proliferation assay, flow cytometry cell cycle analysis, Transwell migration/invasion assay, Western blot, ELISA of serum samples\",\n      \"journal\": \"Frontiers in surgery\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, functional assays without defined upstream/downstream pathway mechanism\",\n      \"pmids\": [\"36684217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In vivo CRISPRa activation of Mrpl9 in mouse liver drives hepatocellular carcinoma tumorigenesis and decreased survival; RNA sequencing revealed that Mrpl9 activation alters genes related to mitochondrial function and promotes cellular proliferation.\",\n      \"method\": \"In vivo CRISPRa screening in mouse liver, validation in separate cohorts with survival analysis, RNA sequencing for transcriptional mechanism\",\n      \"journal\": \"Cellular and molecular gastroenterology and hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gain-of-function with transcriptomic mechanistic follow-up, rigorously validated in separate animals\",\n      \"pmids\": [\"39761726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Loss-of-function of MRPL9 (siRNA knockdown) in TNBC cell lines (MDA-MB-231 and BT-549) inhibited colony-forming unit (CFU) potential and enhanced sensitivity to paclitaxel.\",\n      \"method\": \"siRNA knockdown, colony-forming unit assay, paclitaxel sensitivity assay\",\n      \"journal\": \"Molecular therapy oncolytics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, phenotypic readout without defined molecular pathway\",\n      \"pmids\": [\"34703883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Mouse Mrp genes including Mrpl9 are consistently expressed throughout early embryogenesis with little stage or tissue specificity, and the majority are essential for early embryonic viability with no functional redundancy among family members.\",\n      \"method\": \"Expression analysis during mouse development (RNA data), review of knockout lethality data across Mrp genes\",\n      \"journal\": \"Gene expression patterns : GEP\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic expression profiling with genetic essentiality supported by referenced knockout studies\",\n      \"pmids\": [\"32987154\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MRPL9 is a nucleus-encoded mitochondrial ribosomal protein (homolog of bacterial L3) essential for mitochondrial ribosome function; beyond its structural role in the mitoribosome, MRPL9 interacts with GGCT to activate the MAPK/ERK pathway, promotes cell proliferation and migration in multiple cancer types (thyroid, liver, lung) partly through c-MYC/ZEB1, and drives hepatocellular carcinoma tumorigenesis in vivo by altering mitochondrial function-related gene expression.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEPT papers.\n\n**Classification:**\n\n**RETRIEVED PAPERS:**\n1. [32987154] Expression analysis of mammalian MRP genes — KEEP (canonical MRPL9 context, expression study)\n2. [25296918] Pink1/SNCA double mutant mice, Mrpl9 upregulated — KEEP (mentions Mrpl9 as transcriptional marker, but no mechanistic finding about MRPL9 protein itself — expression correlation only)\n3. [1597181] YmL9/MRP-L9 yeast gene cloned, homologous to L3 — KEEP (ortholog, foundational mechanism)\n4. [34703883] TNBC resistance, MRPL9 loss-of-function inhibits colony formation — KEEP (functional KD)\n5. [36233293] MRPL9-GGCT interaction, MAPK/ERK in thyroid cancer — KEEP (mechanistic)\n6. [34129020] Candida subhashii genome, MRPL9 candidate gene — EXCLUDE (fungal genomics, symbol collision context, no mechanistic finding about human MRPL9)\n7. [8701610] Yeast chromosome VII sequencing, YLM9/MRPL9 mapped — KEEP (ortholog, genomic mapping)\n8. [36684217] HCC molecular subtypes, MRPL9 serum biomarker, cell cycle — KEEP (functional data)\n9. [37343379] Lung cancer, MRPL9 KD inhibits proliferation, c-MYC/ZEB1 pathway — KEEP (mechanistic)\n10. [39761726] CRISPRa screen, Mrpl9 drives HCC, mitochondrial function — KEEP (mechanistic)\n11. [40406416] Diabetic retinopathy, MRPL9 as hub gene in PPI network — EXCLUDE (computational/bioinformatics only)\n12. [37895191] Hanwoo cattle, MRPL9 missense SNP — EXCLUDE (livestock genomics, no mechanistic experiment)\n13. [35674862] PXA lncRNA, LOC728730:MRPL9 pair — EXCLUDE (expression correlation, no mechanistic finding about MRPL9 protein)\n14. [41630109] MRPL13 deficiency in preeclampsia, MRPL9 also decreased — KEEP (MRPL9 protein expression noted, but mechanistic focus is MRPL13; MRPL9 mentioned as co-downregulated)\n\n**ADDITIONAL CURATED PAPERS:**\n- [16169070] BioPlex/Y2H — KEEP (MRPL9 interactions identified)\n- [12477932] MGC cDNA — EXCLUDE (genome resource, no mechanistic finding)\n- [26186194] BioPlex 1.0 — KEEP (MRPL9 interactions)\n- [28514442] BioPlex 2.0 — KEEP (MRPL9 interactions)\n- [26496610] HeLa interactome — KEEP (MRPL9 interactions)\n- [25416956] Human interactome map — KEEP (MRPL9 interactions)\n- [22681889] mRNA-bound proteome — KEEP (MRPL9 identified as RNA-binding)\n- [32296183] HuRI — KEEP (MRPL9 binary interactions)\n- [33961781] BioPlex 3.0 — KEEP (MRPL9 interactions)\n- [22939629] Human protein complexes — KEEP (MRPL9 in complexes)\n- [21873635] GO propagation — EXCLUDE (bioinformatics methodology)\n- [19060904] Y2H framework — EXCLUDE (methodology paper)\n- [29395067] BioID mRNA granules — KEEP (proximity interactions)\n- [15489334] MGC 2004 — EXCLUDE (genome resource)\n- [35271311] OpenCell — KEEP (MRPL9 localization)\n- [26344197] Metazoan complexes — KEEP (MRPL9 in complexes)\n- [8889548] cDNA normalization — EXCLUDE (methodology)\n- [21145461] CRL ubiquitin ligase — EXCLUDE (not about MRPL9)\n- [25278503] Structure of human mt-LSU — KEEP (MRPL9 as component)\n- [34800366] MitoCoP proteome — KEEP (MRPL9 in mitochondrial proteome)\n- [27499296] Mitochondrial protein interaction mapping — KEEP (MRPL9 interactions)\n- [27023846] Structure and function of mitoribosome review — KEEP (MRPL9 context)\n- [11551941] Large subunit of mammalian mitoribosome — KEEP (MRPL9 identified as component)\n- [29568061] MAC-tag AP-MS/BioID — KEEP (MRPL9 interactions)\n- [30833792] ISG interaction network — EXCLUDE (not about MRPL9 specifically)\n- [20186120] ICT1/mitoribosome — KEEP (mitoribosome context)\n- [32877691] Mitochondrial proximity interaction network — KEEP (MRPL9 interactions)\n- [16710414] Human chromosome 1 sequence — EXCLUDE (genome annotation, no mechanistic finding)\n- [31871319] Rho GTPase proximity network — EXCLUDE (not about MRPL9)\n- [28892042] Human mt-LSU assembly intermediates — KEEP (MRPL9 structural context)\n\nNow extracting discoveries from KEPT papers with actual mechanistic content:\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"The yeast nuclear gene YmL9 (MRP-L9), ortholog of human MRPL9, was cloned and sequenced. The encoded protein is a basic 27.5 kDa protein with a putative N-terminal mitochondrial import signal peptide of 19 amino acids. The intact gene is essential for mitochondrial function. YmL9 shows significant sequence similarity to E. coli ribosomal protein L3 and related proteins from all three natural kingdoms, with the highest similarity to eubacterial and cyanelle homologues, locating the conserved structural domain in the C-terminal half.\",\n      \"method\": \"Gene cloning, sequencing, sequence homology analysis, yeast genetics (gene disruption showing essentiality)\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct gene disruption establishing essentiality, sequence characterization with ortholog identification; foundational paper\",\n      \"pmids\": [\"1597181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"MRPL9 (homolog of bacterial L9) was identified as a component of the mammalian mitochondrial ribosome large subunit (39S subunit). Proteolytic digestion of purified bovine 39S subunits followed by LC-MS/MS peptide sequencing confirmed MRPL9 as one of 28 bacterial homolog proteins in the 48-protein complement of the mammalian mt-LSU.\",\n      \"method\": \"Purification of 39S mitochondrial ribosomal subunit, proteolytic digestion, LC-MS/MS peptide sequencing, EST database searching\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical identification from purified ribosomal subunit with mass spectrometry\",\n      \"pmids\": [\"11551941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"MRPL9 was resolved as a structural component of the human mitochondrial large ribosomal subunit (mt-LSU) at 3.4 Å resolution by cryo-EM single-particle analysis. The structure revealed 48 proteins in the mt-LSU, including MRPL9, and showed extensive remodeling of the subunit compared to bacterial ribosomes, with adaptations including a modified exit tunnel for hydrophobic nascent peptides.\",\n      \"method\": \"Single-particle cryo-electron microscopy at 3.4 Å resolution\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — near-atomic resolution cryo-EM structure placing MRPL9 within the mitoribosomal large subunit\",\n      \"pmids\": [\"25278503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MRPL9 was resolved in cryo-EM structures of two late-stage assembly intermediates of the human mt-LSU at ~3 Å resolution, isolated from native cellular pools. These structures revealed the timing of protein incorporation during final steps of ribosomal maturation, showing that MRPL9 is present in the mature mt-LSU and providing insight into evolutionary adaptations required for mitoribosome biogenesis.\",\n      \"method\": \"Cryo-EM of native assembly intermediates isolated from human cells, ~3 Å resolution\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — near-atomic cryo-EM of native ribosomal assembly intermediates\",\n      \"pmids\": [\"28892042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MRPL9 was identified as part of the mitochondrial protein interaction network through affinity enrichment mass spectrometry, placing it within the large subunit of the mitochondrial ribosome and connecting it to diverse mitochondrial processes including respiratory chain function.\",\n      \"method\": \"Affinity enrichment mass spectrometry (condition-specific protein-protein interactions for mitochondrial proteins)\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic AP-MS in mitochondrial context, single study\",\n      \"pmids\": [\"27499296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MRPL9 was confirmed as a high-confidence component of the human mitochondrial proteome (MitoCoP) with defined abundance levels in human cells, contributing to approximately 7% of the cellular proteome occupied by mitochondrial proteins. Its protein half-life dynamics were measured, providing quantitative context for its role in mitoribosome assembly.\",\n      \"method\": \"Quantitative proteomics of mitochondrial preparations, SILAC-based turnover measurements\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic quantitative proteomics with abundance and dynamics measurements\",\n      \"pmids\": [\"34800366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MRPL9 was found to physically interact with GGCT (γ-glutamylcyclotransferase) in papillary thyroid cancer cells. This interaction was demonstrated by co-immunoprecipitation and immunofluorescence co-localization. Knockdown of either MRPL9 or GGCT inhibited MAPK/ERK signaling pathway activation, reduced cell proliferation and migration in vitro, and inhibited subcutaneous xenograft growth and lung metastasis formation in vivo. Conversely, lentiviral overexpression of MRPL9 promoted proliferation and migration.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence co-localization, lentiviral overexpression, siRNA knockdown, xenograft mouse model, lung metastasis model, Western blot for p-ERK/ERK\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — reciprocal Co-IP and in vivo xenograft validation from single lab\",\n      \"pmids\": [\"36233293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Knockdown of MRPL9 in hepatocellular carcinoma (HCC) cells inhibited cell proliferation (CCK8 assay), caused G1/S cell cycle arrest (flow cytometry), and reduced cell migration and invasion (Transwell assay). Overexpressed MRPL9 enhanced aggressiveness. Serum MRPL9 protein levels were significantly elevated in HCC patients compared to healthy individuals and benign liver disease patients, as measured by ELISA.\",\n      \"method\": \"siRNA knockdown, CCK8 proliferation assay, flow cytometry cell cycle analysis, Transwell migration/invasion assay, Western blot, ELISA on patient serum\",\n      \"journal\": \"Frontiers in surgery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — multiple cellular assays plus patient serum validation, single lab\",\n      \"pmids\": [\"36684217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Knockdown of MRPL9 in lung cancer cells inhibited proliferation, sphere formation, and migration. MRPL9 was shown to be functionally associated with the c-MYC signaling pathway; interference with c-MYC expression reduced ZEB1 (an EMT regulator) levels, suggesting MRPL9 exerts its oncogenic effects through regulation of c-MYC which in turn controls ZEB1-mediated epithelial-mesenchymal transition.\",\n      \"method\": \"siRNA knockdown, proliferation assay, sphere-formation assay, migration assay, bioinformatics pathway analysis, siRNA interference of c-MYC with measurement of ZEB1 expression by Western blot\",\n      \"journal\": \"Pathology, research and practice\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — functional KD phenotype with pathway inference partly from bioinformatics; c-MYC/ZEB1 link relies on indirect evidence\",\n      \"pmids\": [\"37343379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In vivo CRISPRa screening in mouse liver identified Mrpl9 as a driver gene of hepatocellular carcinoma. CRISPRa-mediated activation of Mrpl9 (together with oncogenic Myc) resulted in extensive liver tumorigenesis and decreased mouse survival. RNA sequencing of Mrpl9-activated tumors revealed that Mrpl9 upregulation specifically alters expression of genes functionally related to mitochondrial function, leading to promotion of cellular proliferation. This mechanism was distinct from co-identified drivers Vps72 (phospholipid metabolism) and Gba1 (endosomal-lysosomal activity).\",\n      \"method\": \"In vivo CRISPRa screening in mouse liver, RNA sequencing of tumor tissue, survival analysis of mice, validation by independent CRISPRa activation in separate mouse cohorts\",\n      \"journal\": \"Cellular and molecular gastroenterology and hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic gain-of-function screen with RNA-seq mechanistic follow-up and independent validation cohort\",\n      \"pmids\": [\"39761726\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MRPL9 is a conserved, essential component of the mitochondrial ribosome large subunit (mt-LSU), structurally resolved by cryo-EM as a homolog of bacterial L3/L9, where it contributes to mitoribosomal integrity and mitochondrial translation; beyond its ribosomal role, MRPL9 overexpression drives cell proliferation, migration, and tumorigenesis—including as a bona fide HCC driver gene identified by in vivo CRISPRa screening—through mechanisms involving MAPK/ERK pathway activation (partly via physical interaction with GGCT), c-MYC/ZEB1-mediated EMT regulation in lung cancer, and broader alterations in mitochondrial function-related gene expression.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MRPL9 is a nucleus-encoded mitochondrial ribosomal protein, homologous to bacterial ribosomal protein L3, that is essential for mitochondrial translation and early embryonic viability [PMID:1597181, PMID:32987154]. Beyond its structural role in the mitoribosome, MRPL9 physically interacts with GGCT to activate the MAPK/ERK signaling pathway, promoting cell proliferation, migration, and tumor growth in papillary thyroid cancer models [PMID:36233293]. In vivo CRISPRa activation of Mrpl9 in mouse liver is sufficient to drive hepatocellular carcinoma tumorigenesis, with transcriptomic evidence linking its oncogenic activity to altered mitochondrial function-related gene expression and cellular proliferation programs [PMID:39761726].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Cloning of the yeast ortholog established MRPL9 as a nucleus-encoded mitochondrial ribosomal protein homologous to bacterial L3, resolving its identity as a core mitoribosomal component essential for mitochondrial function.\",\n      \"evidence\": \"Gene cloning, sequence analysis, and genetic essentiality testing in yeast\",\n      \"pmids\": [\"1597181\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structural data for MRPL9 within the assembled mitoribosome\",\n        \"Mammalian ortholog function not yet tested\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Systematic analysis of mouse Mrp genes demonstrated that Mrpl9 is ubiquitously expressed in early embryogenesis and essential for embryonic viability without functional redundancy, establishing its non-redundant developmental requirement.\",\n      \"evidence\": \"Expression profiling during mouse development combined with knockout lethality data across Mrp gene family\",\n      \"pmids\": [\"32987154\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific Mrpl9 knockout phenotype not individually characterized in detail\",\n        \"Whether lethality is solely due to loss of mitochondrial translation capacity or additional functions is unknown\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Discovery of a physical interaction between MRPL9 and GGCT, and demonstration that this interaction activates the MAPK/ERK pathway to drive proliferation and metastasis, revealed an unexpected extra-ribosomal signaling function for MRPL9 in cancer.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, immunofluorescence, lentiviral knockdown/overexpression, in vivo xenograft and lung metastasis models in papillary thyroid cancer cells\",\n      \"pmids\": [\"36233293\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural or reconstitution data for the MRPL9–GGCT complex\",\n        \"Whether this interaction occurs outside cancer contexts is unknown\",\n        \"Direct versus indirect activation of ERK not resolved\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Studies in lung cancer and hepatocellular carcinoma extended MRPL9's pro-proliferative role across tumor types, with evidence implicating c-MYC/ZEB1 signaling and G1/S cell cycle progression as downstream effector mechanisms.\",\n      \"evidence\": \"shRNA knockdown with proliferation/migration assays and c-MYC interference experiments in lung cancer cells; overexpression, flow cytometry cell cycle analysis, and serum ELISA in HCC\",\n      \"pmids\": [\"37343379\", \"36684217\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"c-MYC/ZEB1 link is partially inferred from knockdown phenotype and bioinformatics rather than direct biochemical evidence\",\n        \"HCC study lacks defined upstream/downstream pathway mechanism\",\n        \"Findings from single labs without independent replication\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"In vivo CRISPRa activation of Mrpl9 in mouse liver was sufficient to initiate hepatocellular carcinoma, and transcriptomic profiling linked its oncogenic activity to altered mitochondrial function-related gene programs, providing causal in vivo evidence for MRPL9 as an oncogenic driver.\",\n      \"evidence\": \"In vivo CRISPRa screening in mouse liver with survival analysis and RNA sequencing, validated in independent animal cohorts\",\n      \"pmids\": [\"39761726\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether tumorigenesis depends on mitoribosomal function, the GGCT–MAPK axis, or another mechanism is unresolved\",\n        \"No loss-of-function complement in the in vivo liver model\",\n        \"Specific mitochondrial functional alterations not biochemically characterized\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown whether MRPL9's oncogenic activities are mediated through its mitoribosomal function, through extra-ribosomal protein interactions (e.g., GGCT), or through a combination of both, and no structural basis for its non-ribosomal interactions has been established.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No separation-of-function mutants distinguishing ribosomal versus signaling roles\",\n        \"No structural model of MRPL9–GGCT complex\",\n        \"Relationship between MAPK/ERK activation and c-MYC/ZEB1 axis not integrated\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [\"mitochondrial ribosome (39S large subunit)\"],\n    \"partners\": [\"GGCT\"],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait, I made an error in the pathway field — I used a GO term instead of a Reactome ID. Let me fix that.\n\n```json\n{\n  \"mechanistic_narrative\": \"MRPL9 is a nucleus-encoded mitochondrial ribosomal protein, homologous to bacterial ribosomal protein L3, that is essential for mitochondrial translation and early embryonic viability [PMID:1597181, PMID:32987154]. Beyond its structural role in the mitoribosome, MRPL9 physically interacts with GGCT to activate the MAPK/ERK signaling pathway, promoting cell proliferation, migration, and tumor growth in papillary thyroid cancer models [PMID:36233293]. In vivo CRISPRa activation of Mrpl9 in mouse liver is sufficient to drive hepatocellular carcinoma tumorigenesis, with transcriptomic evidence linking its oncogenic activity to altered mitochondrial function-related gene expression and cellular proliferation programs [PMID:39761726].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Cloning of the yeast ortholog established MRPL9 as a nucleus-encoded mitochondrial ribosomal protein homologous to bacterial L3, resolving its identity as a core mitoribosomal component essential for mitochondrial function.\",\n      \"evidence\": \"Gene cloning, sequence analysis, and genetic essentiality testing in yeast\",\n      \"pmids\": [\"1597181\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structural data for MRPL9 within the assembled mitoribosome\",\n        \"Mammalian ortholog function not yet tested\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Systematic analysis of mouse Mrp genes demonstrated that Mrpl9 is ubiquitously expressed in early embryogenesis and essential for embryonic viability without functional redundancy, establishing its non-redundant developmental requirement.\",\n      \"evidence\": \"Expression profiling during mouse development combined with knockout lethality data across Mrp gene family\",\n      \"pmids\": [\"32987154\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific Mrpl9 knockout phenotype not individually characterized in detail\",\n        \"Whether lethality is solely due to loss of mitochondrial translation capacity or additional functions is unknown\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Discovery of a physical interaction between MRPL9 and GGCT, and demonstration that this interaction activates the MAPK/ERK pathway to drive proliferation and metastasis, revealed an unexpected extra-ribosomal signaling function for MRPL9 in cancer.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, immunofluorescence, lentiviral knockdown/overexpression, in vivo xenograft and lung metastasis models in papillary thyroid cancer cells\",\n      \"pmids\": [\"36233293\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural or reconstitution data for the MRPL9–GGCT complex\",\n        \"Whether this interaction occurs outside cancer contexts is unknown\",\n        \"Direct versus indirect activation of ERK not resolved\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Studies in lung cancer and hepatocellular carcinoma extended MRPL9's pro-proliferative role across tumor types, with evidence implicating c-MYC/ZEB1 signaling and G1/S cell cycle progression as downstream effector mechanisms.\",\n      \"evidence\": \"shRNA knockdown with proliferation/migration assays and c-MYC interference experiments in lung cancer cells; overexpression, flow cytometry cell cycle analysis, and serum ELISA in HCC\",\n      \"pmids\": [\"37343379\", \"36684217\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"c-MYC/ZEB1 link is partially inferred from knockdown phenotype and bioinformatics rather than direct biochemical evidence\",\n        \"HCC study lacks defined upstream/downstream pathway mechanism\",\n        \"Findings from single labs without independent replication\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"In vivo CRISPRa activation of Mrpl9 in mouse liver was sufficient to initiate hepatocellular carcinoma, and transcriptomic profiling linked its oncogenic activity to altered mitochondrial function-related gene programs, providing causal in vivo evidence for MRPL9 as an oncogenic driver.\",\n      \"evidence\": \"In vivo CRISPRa screening in mouse liver with survival analysis and RNA sequencing, validated in independent animal cohorts\",\n      \"pmids\": [\"39761726\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether tumorigenesis depends on mitoribosomal function, the GGCT–MAPK axis, or another mechanism is unresolved\",\n        \"No loss-of-function complement in the in vivo liver model\",\n        \"Specific mitochondrial functional alterations not biochemically characterized\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown whether MRPL9's oncogenic activities are mediated through its mitoribosomal function, through extra-ribosomal protein interactions (e.g., GGCT), or through a combination of both, and no structural basis for its non-ribosomal interactions has been established.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No separation-of-function mutants distinguishing ribosomal versus signaling roles\",\n        \"No structural model of MRPL9–GGCT complex\",\n        \"Relationship between MAPK/ERK activation and c-MYC/ZEB1 axis not integrated\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 6]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"complexes\": [\"mitochondrial ribosome (39S large subunit)\"],\n    \"partners\": [\"GGCT\"],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"MRPL9 is a conserved structural component of the mitochondrial ribosome large subunit (mt-LSU), essential for mitochondrial translation and oxidative phosphorylation. The protein was identified biochemically as one of 48 proteins of the mammalian 39S mt-LSU and resolved at near-atomic resolution by cryo-EM within both the mature mt-LSU and late-stage assembly intermediates, where it occupies a position homologous to bacterial ribosomal protein L9 [PMID:11551941, PMID:25278503, PMID:28892042]. Beyond its canonical ribosomal role, MRPL9 overexpression drives cell proliferation and tumorigenesis: in vivo CRISPRa screening identified Mrpl9 as a hepatocellular carcinoma driver gene whose activation alters mitochondrial function-related gene expression programs [PMID:39761726], while in papillary thyroid cancer cells MRPL9 physically interacts with GGCT to activate MAPK/ERK signaling and promote proliferation, migration, and metastasis [PMID:36233293]. Knockdown of MRPL9 in hepatocellular carcinoma and lung cancer cells consistently suppresses proliferation, migration, and invasion, with downstream effects on cell cycle progression and c-MYC/ZEB1-mediated epithelial–mesenchymal transition [PMID:36684217, PMID:37343379].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Cloning of the yeast ortholog YmL9 established that the MRPL9 gene family encodes a mitochondrial ribosomal protein homologous to bacterial L3, and gene disruption demonstrated its essentiality for mitochondrial function — answering whether this nuclear-encoded protein is required for organellar translation.\",\n      \"evidence\": \"Gene cloning, sequencing, and disruption in S. cerevisiae\",\n      \"pmids\": [\"1597181\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mammalian MRPL9 not yet identified or characterized\",\n        \"Precise position within the ribosome unknown\",\n        \"Mechanism of mitochondrial import not defined\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Direct biochemical identification of MRPL9 in purified bovine 39S subunits confirmed it as a bona fide mammalian mt-LSU component, resolving whether the bacterial homolog was retained in the heavily remodeled mammalian mitoribosome.\",\n      \"evidence\": \"Proteolytic digestion and LC-MS/MS of purified bovine 39S mitoribosomal subunits\",\n      \"pmids\": [\"11551941\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structural information on MRPL9's position within the subunit\",\n        \"Functional contribution to translation not directly tested in mammalian cells\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Cryo-EM structures of the human mt-LSU at 3.4 Å placed MRPL9 within the architectural context of the mature ribosome, revealing how mitoribosomal remodeling accommodates hydrophobic nascent chains — the first direct structural view of MRPL9 in situ.\",\n      \"evidence\": \"Single-particle cryo-EM at 3.4 Å resolution of human mt-LSU\",\n      \"pmids\": [\"25278503\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Timing of MRPL9 incorporation during ribosome assembly unknown\",\n        \"Functional contacts with rRNA or neighboring proteins not individually characterized\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Resolution of native late-stage assembly intermediates showed that MRPL9 is present in pre-mature mt-LSU complexes, establishing its incorporation timing during mitoribosome biogenesis.\",\n      \"evidence\": \"Cryo-EM of native mt-LSU assembly intermediates at ~3 Å from human cells\",\n      \"pmids\": [\"28892042\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Specific assembly factors that recruit MRPL9 not identified\",\n        \"Consequence of MRPL9 depletion on assembly intermediate accumulation not tested\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Discovery of a physical MRPL9–GGCT interaction linked MRPL9 to MAPK/ERK signaling and cancer cell proliferation/metastasis, raising the question of whether MRPL9 has extra-ribosomal oncogenic functions.\",\n      \"evidence\": \"Co-immunoprecipitation, immunofluorescence co-localization, xenograft and lung metastasis models in papillary thyroid cancer\",\n      \"pmids\": [\"36233293\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the MRPL9–GGCT interaction occurs in the mitochondrial matrix or cytosol is unclear\",\n        \"Whether ERK activation is a direct consequence of the interaction or secondary to altered mitochondrial function is unresolved\",\n        \"Single-lab finding not yet independently replicated\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Functional studies in HCC and lung cancer cells demonstrated that MRPL9 knockdown consistently suppresses proliferation, migration, and invasion, with evidence linking MRPL9 to c-MYC/ZEB1-mediated EMT in lung cancer — broadening the cancer types where MRPL9 overexpression is functionally relevant.\",\n      \"evidence\": \"siRNA knockdown with proliferation, migration, invasion, and cell cycle assays in HCC and lung cancer cell lines; patient serum ELISA; Western blot for c-MYC and ZEB1\",\n      \"pmids\": [\"36684217\", \"37343379\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The c-MYC/ZEB1 link relies partly on bioinformatic inference and indirect knockdown experiments\",\n        \"Whether pro-tumorigenic effects depend on MRPL9's ribosomal function or an independent activity is unknown\",\n        \"Elevated serum MRPL9 in HCC patients not validated in independent cohorts\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"In vivo CRISPRa screening identified Mrpl9 as a bona fide hepatocellular carcinoma driver whose gain-of-function alters mitochondrial function gene programs and accelerates tumorigenesis, directly linking MRPL9's mitochondrial biology to its oncogenic capacity.\",\n      \"evidence\": \"In vivo CRISPRa screen in mouse liver with Myc co-activation, RNA-seq of tumors, independent validation cohorts\",\n      \"pmids\": [\"39761726\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether MRPL9-driven tumorigenesis requires intact mitoribosomal incorporation or occurs through a ribosome-independent mechanism is unresolved\",\n        \"Specific mitochondrial pathways altered (OXPHOS, ROS, metabolites) not dissected at protein level\",\n        \"Cooperation with Myc complicates attribution of tumor phenotype to MRPL9 alone\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown whether the pro-tumorigenic effects of MRPL9 overexpression are mediated through enhanced mitochondrial translation, altered mitochondrial metabolism, extra-ribosomal protein interactions, or a combination of these mechanisms.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No separation-of-function mutants distinguishing ribosomal from extra-ribosomal roles\",\n        \"No structural basis for the MRPL9–GGCT interaction\",\n        \"Effects of MRPL9 loss on mitochondrial translation in mammalian cells not directly measured\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [1, 2, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1, 2, 3, 4, 5]},\n      {\"term_id\": \"GO:0005840\", \"supporting_discovery_ids\": [1, 2, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [1, 2, 3]}\n    ],\n    \"complexes\": [\n      \"mitochondrial ribosome large subunit (39S)\"\n    ],\n    \"partners\": [\n      \"GGCT\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}